Adia Med Kicks Off Recruitment Today for Innovative Autism Stem Cell Study
Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia...
Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia...
Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile Corp. - January 13, 2026)...
Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits, evidence-informed clinical education, and hands-on...
Total Revenue Expected to be $276 Million MACI Revenue Expected to be $239.5 Million Fourth Quarter Total Revenue and MACI...
Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance policies leave stroke survivors with...
Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large, engaged patient populationATLANTA , Jan....
American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key...
TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company...
MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of...
- A seasoned healthcare executive with nearly two decades of leadership experience, Mr. Jovan Hollins will lead ClinNEXUS’ operations at...
KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first...
AMAR regulatory approval will allow the Company to launch ZSmile in Israel in 2026 as a precursor to a larger...
Nu-Tek Manufacturing Facility Nu-Tek's state-of-the-art facility, purpose built to provide over 2000 metric tons of animal-free production annually. Nu-Tek BioSciences...
– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising...
CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma,...
Company Remains Fully Committed to Advancing Its Core Intranasal Medical Pipeline, alongside examining new opportunities including in fields of aviation,...
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic systemFORT LAUDERDALE, Fla., Jan. 13, 2026...
Cherry Hill, NJ, Jan. 13, 2026 (GLOBE NEWSWIRE) -- LifeRx, a trusted telehealth and wellness company specializing in metabolic, hormonal,...
The minimally dilutive funding will accelerate Pelthos’ highly successful commercialization efforts for its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3%...
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a...